Sukhbinder Dhesy‐Thind

1.9k total citations
50 papers, 1.3k citations indexed

About

Sukhbinder Dhesy‐Thind is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Sukhbinder Dhesy‐Thind has authored 50 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 12 papers in Radiology, Nuclear Medicine and Imaging and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Sukhbinder Dhesy‐Thind's work include HER2/EGFR in Cancer Research (8 papers), Palliative Care and End-of-Life Issues (6 papers) and Bone health and treatments (6 papers). Sukhbinder Dhesy‐Thind is often cited by papers focused on HER2/EGFR in Cancer Research (8 papers), Palliative Care and End-of-Life Issues (6 papers) and Bone health and treatments (6 papers). Sukhbinder Dhesy‐Thind collaborates with scholars based in Canada, United States and Ireland. Sukhbinder Dhesy‐Thind's co-authors include Peter Ellis, Som D. Mukherjee, Melissa S. Dillmon, Mark Clemons, Elizabeth Frank, Catherine Van Poznak, Beverly Moy, Darryl P. Leong, Mihaela Mates and Scot Dowden and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Sukhbinder Dhesy‐Thind

49 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sukhbinder Dhesy‐Thind Canada 17 842 299 263 173 173 50 1.3k
Haider Mahdi United States 22 509 0.6× 189 0.6× 157 0.6× 70 0.4× 148 0.9× 121 1.7k
Sung Hoon Sim South Korea 18 493 0.6× 230 0.8× 325 1.2× 99 0.6× 75 0.4× 81 1.0k
Maureen Ross United States 20 1.0k 1.2× 426 1.4× 288 1.1× 85 0.5× 182 1.1× 61 1.8k
Herbert Stöger Austria 19 562 0.7× 158 0.5× 259 1.0× 49 0.3× 252 1.5× 68 1.1k
Pierre-Étienne Heudel France 17 558 0.7× 133 0.4× 319 1.2× 110 0.6× 95 0.5× 95 990
Florian Kocher Austria 18 498 0.6× 160 0.5× 357 1.4× 117 0.7× 89 0.5× 72 990
Enrique González‐Billalabeitia Spain 19 580 0.7× 399 1.3× 365 1.4× 61 0.4× 157 0.9× 75 1.3k
Ngan‐Ming Tsang Taiwan 20 553 0.7× 258 0.9× 200 0.8× 159 0.9× 159 0.9× 57 1.3k
Michele De Tursi Italy 18 576 0.7× 304 1.0× 310 1.2× 50 0.3× 117 0.7× 60 1.3k
Deborah Driscoll United States 23 630 0.7× 113 0.4× 415 1.6× 102 0.6× 323 1.9× 34 1.6k

Countries citing papers authored by Sukhbinder Dhesy‐Thind

Since Specialization
Citations

This map shows the geographic impact of Sukhbinder Dhesy‐Thind's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sukhbinder Dhesy‐Thind with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sukhbinder Dhesy‐Thind more than expected).

Fields of papers citing papers by Sukhbinder Dhesy‐Thind

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sukhbinder Dhesy‐Thind. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sukhbinder Dhesy‐Thind. The network helps show where Sukhbinder Dhesy‐Thind may publish in the future.

Co-authorship network of co-authors of Sukhbinder Dhesy‐Thind

This figure shows the co-authorship network connecting the top 25 collaborators of Sukhbinder Dhesy‐Thind. A scholar is included among the top collaborators of Sukhbinder Dhesy‐Thind based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sukhbinder Dhesy‐Thind. Sukhbinder Dhesy‐Thind is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dhesy‐Thind, Sukhbinder, et al.. (2024). The Significance of Thyroid Hormone Receptors in Breast Cancer: A Hypothesis-Generating Narrative Review. Current Oncology. 31(5). 2364–2375. 3 indexed citations
2.
Kavsak, Peter A., Joshua O. Cerasuolo, David H. Kirkwood, et al.. (2024). High-Sensitivity Cardiac Troponin I for Long-Term Cardiovascular Risk Stratification in a Cancer Clinic Population. JACC CardioOncology. 6(1). 136–138. 2 indexed citations
3.
Kavsak, Peter A., et al.. (2023). Detection of Macrotroponin in Patients Receiving Treatment for Breast Cancer. CJC Open. 5(8). 658–660. 5 indexed citations
4.
Portillo, Ana L., Richard T. Hogg, Sophie M. Poznanski, et al.. (2021). Expanded human NK cells armed with CAR uncouple potent anti-tumor activity from off-tumor toxicity against solid tumors. iScience. 24(6). 102619–102619. 51 indexed citations
5.
Levine, Oren, Sukhbinder Dhesy‐Thind, Meghan McConnell, Melissa Brouwers, & Som D. Mukherjee. (2020). Code Status Communication Training in Postgraduate Oncology Programs: A Needs Assessment. Current Oncology. 27(6). 607–613. 2 indexed citations
6.
Awan, Arif, Terry L. Ng, Henry Jacob Conter, et al.. (2020). Feasibility outcomes of a randomised, multicentre, pilot trial comparing standard 6-monthly dosing of adjuvant zoledronate with a single one-time dose in patients with early stage breast cancer. Journal of bone oncology. 26. 100343–100343. 5 indexed citations
7.
Donovan, E., Sukhbinder Dhesy‐Thind, Som D. Mukherjee, Michael Jonathan Kucharczyk, & Anand Swaminath. (2019). Attitudes and beliefs toward the use of stereotactic body radiotherapy in oligometastatic breast cancer: A commentary on a survey of Canadian Medical Oncologists. The Breast Journal. 25(6). 1222–1224. 5 indexed citations
8.
Donovan, E., Sukhbinder Dhesy‐Thind, Anand Swaminath, et al.. (2019). MEDiastinal Irradiation and CArdio-Toxic Effects (MEDICATE): Exploring the Relationship between Cardiac Irradiation and High Sensitivity Troponins. Clinical Oncology. 31(7). 479–485. 4 indexed citations
9.
Farooqi, Mohammed A., Som D. Mukherjee, Stephanie Sanger, et al.. (2018). Statin therapy in the treatment of active cancer: A systematic review and meta-analysis of randomized controlled trials. PLoS ONE. 13(12). e0209486–e0209486. 52 indexed citations
10.
Clark, David A., et al.. (2018). Soluble CD200 in secretory phase endometriosis endometrial venules may explain endometriosis pathophysiology and provide a novel treatment target. Journal of Reproductive Immunology. 129. 59–67. 11 indexed citations
11.
Dhesy‐Thind, Sukhbinder, et al.. (2018). Clinical Practice Guidelines in Breast Cancer. Current Oncology. 25(11). 151–160. 58 indexed citations
12.
Martin, Leslie, Ameen Patel, Matthew Patel, et al.. (2018). Role of allied health care professionals in goals-of-care discussions with hospitalized patients and perceived barriers: a cross-sectional survey. CMAJ Open. 6(2). E241–E247. 3 indexed citations
13.
Jerzak, Katarzyna J., Sukhbinder Dhesy‐Thind, Gregory R. Pond, et al.. (2018). Thyroid hormone receptor beta-1 expression in early breast cancer: a validation study. Breast Cancer Research and Treatment. 171(3). 709–717. 15 indexed citations
14.
Shenouda, Mira M., Amy Gillgrass, Tina Nham, et al.. (2017). Ex vivo expanded natural killer cells from breast cancer patients and healthy donors are highly cytotoxic against breast cancer cell lines and patient-derived tumours. Breast Cancer Research. 19(1). 76–76. 58 indexed citations
15.
Meyers, Brandon M., Humaid O. Al‐Shamsi, Radhika Yelamanchili, et al.. (2017). Utility of the Edmonton Frail Scale in identifying frail elderly patients during treatment of colorectal cancer. Journal of Gastrointestinal Oncology. 8(1). 32–38. 23 indexed citations
16.
Bernstein, Vanessa, Susan Ellard, Susan Dent, et al.. (2017). A randomized phase II study of weekly paclitaxel with or without pelareorep in patients with metastatic breast cancer: final analysis of Canadian Cancer Trials Group IND.213.. Breast Cancer Research and Treatment. 167(2). 485–493. 79 indexed citations
17.
O’Brien, Mary Ann, et al.. (2017). Uptake of a 21-Gene Expression Assay in Breast Cancer Practice: Views of Academic and Community-Based Oncologists. Current Oncology. 24(2). 138–145. 1 indexed citations
18.
You, John J., Kathleen I. Pritchard, Ian S. Dayes, et al.. (2015). 18F-fluorodeoxyglucose positron-emission tomography-computed tomography to diagnose recurrent cancer. British Journal of Cancer. 112(11). 1737–1743. 15 indexed citations
19.
20.
Jerzak, Katarzyna J., Gregory R. Pond, Kathleen I. Pritchard, et al.. (2014). Thyroid hormone receptor α in breast cancer: prognostic and therapeutic implications. Breast Cancer Research and Treatment. 149(1). 293–301. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Haider Mahdi Breakdown of academic impact, for papers by Sung Hoon Sim Breakdown of academic impact, for papers by Maureen Ross Breakdown of academic impact, for papers by Herbert Stöger Breakdown of academic impact, for papers by Pierre-Étienne Heudel Breakdown of academic impact, for papers by Florian Kocher Breakdown of academic impact, for papers by Enrique González‐Billalabeitia Breakdown of academic impact, for papers by Ngan‐Ming Tsang Breakdown of academic impact, for papers by Michele De Tursi Breakdown of academic impact, for papers by Deborah Driscoll
Rankless by CCL
2026